Sleep Strategies
-
A ‘central’ issue in sleep medicine
An AASM task force recently published guidelines on central sleep apnea management, which includes recommendations on whether adaptive servo-ventilation is a safe option in these patients.
-
CMS releases updated guidance for NIPPV in patients with COPD
Understand the new CMS guidance, which comes after more than a decade of strategic advocacy efforts led by CHEST.
-
Using consumer sleep trackers in clinical practice
Consumer sleep technologies are offering new ways to monitor sleep. Clinicians need to be prepared to discuss this data, clarify limitations, and interpret findings with patients.
-
OSA and the Alzheimer’s continuum
OSA is being increasingly recognized as a potential contributor to neurodegeneration, particularly in the preclinical stages of Alzheimer’s disease. As early intervention becomes a priority in Alzheimer’s prevention, sleep disorders are being investigated as modifiable risk factors.
-
Reexamining treatment for RLS: What do the new AASM guidelines teach us?
The key clinical takeaway from the new guidelines is that dopamine agonists are no longer first-line therapy for RLS, and gabapentinoids should be used as primary therapy for most patients.
-
Should napping be recommended as a health behavior?
The quest for an effective, inexpensive, and manageable intervention for sleep loss often leads to the question: What about naps? Author Sara C. Mednick, PhD, lists the pros and cons.
-
OSA in pregnancy: Who to test, how to screen, and does treatment help?
The estimated prevalence of OSA in pregnancy ranges from 4% to 27% compared with 0.7% to 6.5% in nonpregnant, reproductive-age females, with an even higher prevalence in complicated pregnancies.1 The increased prevalence in pregnancy can be explained by physiologic changes impacting the upper airway such as increases in maternal blood volume and reductions in oncotic…
-
On 5 Ps: PSG, PM, PPG, PulseOx, and PAT
OSA is a very prevalent condition in the general population, but still many patients remain undiagnosed and untreated. Prolonged, untreated OSA is an independent risk factor for major cardiovascular morbidity and mortality. Therefore, timely diagnosis and treatment are required. Polysomnography (PSG) remains to this day the gold standard for diagnosing sleep apnea. A standard PSG…
-
Home ventilation consult
Philips Respironics released a public statement on January 25, 2024, that would dramatically change the landscape of home mechanical ventilation and sleep-disordered breathing management in the United States. The company announced that, effective immediately in the US and US territories, Philips Respironics would stop production and sale of all hospital and home mechanical ventilation products,…
-
Daylight Saving Time: Saving light but endangering health
The American Academy of Sleep Medicine recently published its position statement reaffirming its support of utilizing permanent Standard Time (ST) as opposed to Daylight Saving Time (DST).1 DST usually occurs on the second Sunday in March when we “spring forward” by advancing the clock by 1 hour. The analogous “fall back” on the first Sunday…
